DPHARMA

Second Interim Dividend (with Dividend Re-Investment Plan)

DUOPHARMA BIOTECH BERHAD

Entitlement subject Second Interim Dividend (with Dividend Re-Investment Plan)
Entitlement description
Second Interim Dividend of 1.8 sen per ordinary share
Ex-Date 07 Apr 2023
Entitlement date 10 Apr 2023
Entitlement time 5:00 PM
Financial Year End 31 Dec 2022
Share transfer book & register of members will be  to  closed from (both dates inclusive) for the purpose of determining the entitlement
Payment Date 09 May 2023
a.Securities transferred into the Depositor's Securities Account before 4:30 pm in respect of transfers 10 Apr 2023
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units)
(If applicable)
Entitlement indicator Currency
Entitlement in Currency Malaysian Ringgit (MYR)  0.0180
Options Available to Shareholders Cash or Securities

Cash

Cash^ Entitlement

1
Tax Indicator Tax Exempt / Non-taxable
Currency Malaysian Ringgit (MYR)
Amount 0.0180

or Securities

Re-invest Cash Entitlement into Securities
Entitlement Malaysian Ringgit (MYR)  0.0180
Company Name
DUOPHARMA BIOTECH BERHAD
Issue Price per Unit Malaysian Ringgit (MYR) 1.3500
Deadline To Respond 26 Apr 2023 05:00 PM
Securities Crediting Date 09 May 2023
Available/Listing Date 10 May 2023
Fractional Entitlement Cash in Lieu of Fraction
Malaysian Ringgit (MYR) 1.3500 per unit
Note: You will receive Cash^ if you do not Re-invest.

Registrar or Service Provider name, address, telephone no TRICOR INVESTOR & ISSUING HOUSE SERVICES SDN BHD
Unit 32-01, Level 32, Tower A,
Vertical Business Suite, Avenue 3, Bangsar South,

No. 8, Jalan Kerinchi

59200 Kuala Lumpur

Wilayah Persekutuan

Malaysia

Tel:0327839299
Fax:0327839222


Remarks :
On 23 February 2023, the Board of Directors of Duopharma Biotech Berhad ("Duopharma Biotech" or the "Company") ("Board") declared a second interim dividend of 1.8 sen per ordinary share in Duopharma Biotech ("Duopharma Biotech Share") in respect of the financial year ended 31 December 2022 and resolved that the dividend reinvestment plan, which was approved at the Company's Extraordinary General Meeting held on 31 May 2018 ("DRP"), would apply to the said second interim dividend.

Following the above, on behalf of the Board, AmInvestment Bank Berhad had on 27 March 2023, announced that the issue price of the new Duopharma Biotech Shares to be issued pursuant to the DRP has been fixed at RM1.35 per new Duopharma Biotech Share.

This Announcement is dated 27 March 2023.


Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 27 Mar 2023
Category Entitlement(Notice of Book Closure)
Reference Number ENT-27032023-00002
Corporate Action ID MY230327DRIP0001


View original